Why Hims & Hers Stock Crashed on Tuesday

Could a competitor lowering prices eat into Hims & Hers market share? Shares of Hims & Hers (HIMS -7.54%) fell as much as 8% on Tuesday and closed at their low for the day after news broke that Eli Lilly (LLY 0.42%) lowered the price for a key weight loss drug. Eli Lilly's shot at Hims & Hers The big news on Tuesday was an announcement that Eli Lilly will sell the weight loss drug Zepbound through its direct-to-consumer website at a 50% discount to the previous price. A 2.5 milligram single-dose vial will c ...